COVID-19 test kit ErbaLisa

IgMSARS-COV-2serum

CE-marked Enzyme Immunoassay (ELISA) kit for the detection of IgM antibodies to SARS-CoV-2 in human serum. Main Features: Number of tests: 96 Principle: Indirect ELISA using recombinant Spike (S) subunit and Nucleocapsid (N) antigens Tracer: HRP-Labelled Anti-human IgM Assay format: Semi-quantitative Sample Size: 100 μL (1:21 Dilution) Reading wavelength: 450nm Storage: 2-8ºC Built for convenience: Ready to use reagents Removable strips Break-apart wells All incubation steps at room temperature Interchangeable reagents Calibrator and Controls included Ready for automation 1:21 sample dilution can be performed validated on microwell plate Performance characteristics: 30 serum samples collected from previously RT-PCR confirmed COVID-19 patients were tested. 50 normal healthy patients with samples collected before COVID-19 outbreak (prior to December 2019) were tested. The results are as follows: Validation conducted in the USA. Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.